Chicago Equity Partners’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-21,418
| Closed | -$1.32M | – | 664 |
|
|
2019
Q4 | $1.32M | Sell |
21,418
-18,250
| -46% | -$1.13M | 0.08% | 381 |
|
|
2019
Q3 | $2.89M | Sell |
39,668
-7,800
| -16% | -$568K | 0.14% | 221 |
|
|
2019
Q2 | $3.9M | Sell |
47,468
-300
| -0.6% | -$24.7K | 0.17% | 154 |
|
|
2019
Q1 | $3.37M | Buy |
47,768
+615
| +1% | +$43.4K | 0.13% | 221 |
|
|
2018
Q4 | $2.12M | Buy |
47,153
+7,595
| +19% | +$342K | 0.09% | 326 |
|
|
2018
Q3 | $2.24M | Buy |
39,558
+1,483
| +4% | +$83.9K | 0.07% | 354 |
|
|
2018
Q2 | $2.54M | Buy |
38,075
+19,355
| +103% | +$1.29M | 0.08% | 339 |
|
|
2018
Q1 | $1.09M | Sell |
18,720
-3,850
| -17% | -$224K | 0.03% | 486 |
|
|
2017
Q4 | $1.46M | Hold |
22,570
| – | – | 0.04% | 429 |
|
|
2017
Q3 | $1.19M | Buy |
22,570
+2,745
| +14% | +$144K | 0.04% | 481 |
|
|
2017
Q2 | $928K | Buy |
19,825
+2,465
| +14% | +$115K | 0.03% | 517 |
|
|
2017
Q1 | $859K | Buy |
17,360
+860
| +5% | +$42.6K | 0.02% | 486 |
|
|
2016
Q4 | $1M | Buy |
16,500
+4,300
| +35% | +$261K | 0.03% | 462 |
|
|
2016
Q3 | $809K | Buy |
+12,200
| New | +$809K | 0.02% | 467 |
|